jardiance glp 1 Improves Life Expectancy for Adults With Type 2 Diabetes and Cardiovascular Disease Jardiance (empagliflozin) prescription available

Roche reveals first data with Carmot-sourced oral GLP-1 drug Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.1 billion takeover of Carmot Therapeutics as it tries to catch up with the leaders in the fast-growing category

Ingenbleek Y, McCully KS

This property is directly related to its gastric origin: it resists enzymatic degradation in the stomach, which opens the door to oral administration a considerable advantage over other peptides that strictly require injection

A compromised immune system, poor gut health, and food sensitivities may also cause the condition